Skip to Main Navigation Skip to Main Content Skip to Footer
search play2 play3 facebook twitter linkedin2 cross instagram
ASCP
  • DASHBOARD
  • STORE
  • LOGOUT
  • STORE
  • LOGIN
Menu
  • Membership
    • Membership Overview
      • Become a Member
      • Member Testimonials
    • Member Resources
      • My Dashboard
      • Manage My Education
      • Renew My Membership
      • Member Center
      • Find a Mentorship
      • Councils & Committees
      • Volunteer Opportunities
      • Awards & Recognition
      • Member Rewards
      • Lab Week
      • ASCP News
    • My Role
      • Pathologist
      • Laboratory Professional
      • Pathology Resident
      • Residency Program Director
      • Lab Sciences Program Director
      • Laboratory Science Student
      • Medical Student
    • Career Resources
      • Find a Job
      • Post a Job
      • Find a Pathology Fellowship
      • Post a Fellowship
      • Learn About Careers
      • Scholarships & Grants
  • Learning
    • Learning Overview
    • Certificate Programs
      • Lab Management University
      • University of Path Informatics
      • Leadership Institute
    • Live Events
      • ASCP Annual Meeting
      • Virtual Pathology Grand Rounds
      • KnowledgeLab
    • Resources
      • Access My Education
      • Manage CMP
      • Manage CC
    • ASCPedia
    • Online Education
      • Online CE Packages
      • LabQ
      • Case Reports
      • Resident Question Bank (RQB)
      • MLS Online Review Course
      • Webcasts
      • Patient Safety
      • Featured Education
    • Quality Improvement & Quality Assurance
      • Continuous Quality Improvement (CQI)
      • National Pathology Quality Registry (NPQR)
      • CheckPath
      • GYN Assessment
      • Non-GYN Assessment
      • GYN Proficiency Testing
    • Books & Journals
      • Books
      • American Journal of Clinical Pathology (AJCP)
      • Lab Medicine
      • Critical Values
    • ACCME ACCREDITATION
  • Advocacy & Outreach
    • Institute For Science Technology, and Public Policy
      • ASCP Policy Efforts
      • Choosing Wisely
      • Guidelines & Resources
      • Workforce Initiatives
      • ePolicy News
    • Center For Global Health
      • Overview
      • Communicable Diseases (HIV)
      • Non-Communicable Diseases (Cancer)
      • Volunteer with CGH
    • ASCP Foundation
      • Make a Donation
      • Providing Scholarships, Grants, & Fellowships
      • Improving Global Health
      • Increasing Lab Visibility
      • ASCP General Fund
      • Ways to Donate
    • Get Involved
      • Discover Opportunities to Get Involved
      • Foster Diversity & Inclusion
      • ASCP Councils & Committees
      • Career Ambassadors
      • Pathology Ambassadors
      • Discover Mentorships
      • Apply to Volunteer
    • Laboratory Excellence
      • Leading Laboratories
      • National Pathology Quality Registry (NPQR)
      • Awards & Recognition
      • Lab Week
    • Patient Champions
  • About ASCP
    • About ASCP
      • ASCP Mission
      • Supporting Our Members
      • ASCP Foundation
      • Community Efforts
      • Work at ASCP
    • Contact Us
  • Board of Certification
    • BOC home
    • About The BOC
      • About the BOC
        • BOC Structure
          • BOC Mission
          • BOC Partners
          • Contact BOC
          • Appeals
        • News and Reports
          • Newsletters
          • Statistics / Practice Analyses
      • What We Do
        • Our Services
          • Certs & Quals
          • CMP
          • Verify Credentials
      • Governance
        • Committees
          • Exam Committee
          • Board of Governors
        • International Governance
          • Advisory Boards
          • Collaborating Societies
      • Volunteer
        • Volunteer Opportunities
          • Exam Committees
          • International Volunteer Opportunities
          • ASCP
    • Get Credentialed
      • Certification Exam Process
        • Get Ready to Apply
          • General Information
          • Determine Category & Route
          • Compare US & International Certification
        • Gather Documentation
          • US Certification
          • International Certication
          • US Military
        • Before Exam
          • Schedule a Date
          • Study Materials
        • Exam Day
          • The Test Center
          • The Examination
        • After Exam
          • Pass The Exam
          • Fail The Exam
      • U.S. Certifications
        • Highest Volume
          • HT
          • MLS
          • MLT
          • PBT
        • Technician
          • HT
          • MLA
          • MLT
          • PBT
          • DPT
        • Technologist/Scientists
          • BB
          • C
          • CG
          • CT
          • H
          • HTL
          • M
          • MB
          • MLS
        • Specialist
          • SBB
          • SC
          • SCT
          • SCYM
          • SH
          • SM
          • SMB
        • Additional
          • DLM
          • PA
      • International Certifications
        • Highest Volume
          • MB
          • MLS
          • MLT
          • PBT
        • Technician
          • HT
          • MLT
          • PBT
        • Technologist/Scientists
          • BB
          • MB
          • MLS
          • C
          • CG
          • CLM
          • CT
          • CTGYN
          • H
          • HLT
          • M
        • Specialist
          • SBB
          • SC
          • SCT
          • SCYM
          • SH
          • SM
          • SMB
      • Qualifications
        • Get Ready to Apply
          • General Information
          • Determine Category and Exam Route
          • Gather Document
        • Examination
          • Take the Exam
          • Pass the Exam
          • Fail the Exam
        • Qualifications
          • QBRS
          • QDP
          • QIA
          • QIHC
          • QLS
      • State Licensure
        • California State Licensure
          • California State Licensure Only
          • ASCP Certification & CA Licensure
          • Already ASCP Certified
        • New York State Licensure
          • New York State Licensure Only
          • ASCP Certification & NY Licensure
          • Already ASCP Certified
        • Additional Licensure States
          • Florida
          • Hawaii
          • Louisiana
          • Montana
          • Nevada
          • North Dakota
          • Tennesee
          • West Virginia
          • Puerto Rico
    • Stay Credentialed
      • Information About CMP
        • CMP Overview
          • CMP Process
          • Synchronize Multiple Credentials
        • Credential Status
          • Mandatory
          • Voluntary
          • Expired
          • Inactive
        • How to Manage Points
          • How to Earn Points
          • How to Record Points
          • Suggested CE Providers
          • When to Submit a CMP Declaration
          • COVID Related CE Form
      • U.S. Certifications
        • Highest Volume
          • HT
          • MLS
          • MLT
          • PBT
        • Technician
          • HT
          • MLA
          • MLT
          • PBT
          • AT
          • DPT
        • Technologist/Scientists
          • BB
          • C
          • CG
          • CT
          • H
          • HTL
          • M
          • MB
          • MLS
        • Specialist
          • SBB
          • SC
          • SCT
          • SCYM
          • SH
          • SM
          • SMB
          • HP
          • SLS
          • SV
        • Additional
          • DLM
          • PA
      • International Certifications
        • Highest Volume
          • MB
          • MLS
          • MLT
          • PBT
        • Technician
          • HT
          • MLT
          • PBT
        • Technologist/Scientists
          • BB
          • C
          • CG
          • CLM
          • CT
          • CTGYN
          • H
          • HTL
          • M
          • MB
          • MLS
        • Specialist
          • SBB
          • SC
          • SCT
          • SCYM
          • SH
          • SM
          • SMB
      • Qualifications
        • Qualifications
          • QBRS
          • QDP
          • QIA
          • QIHC
          • QLI
          • QLS
    • Verify Credentials
      • General Information
        • Topics
          • Citation of Credentials
          • Fraudulent Use of Credentials
          • Replacement Wall Certificates
      • How to Verify
        • Options for Verifying Credentials
          • Getting Started
          • For Certification/Qualification
          • For State Licensure
          • For Visa Screen
          • Place an Order
    • Program Directors
      • Program Director Resources
        • Resources
          • BOC Resources
          • Accreditation Agencies
      • Manage Your Students
        • Tools & Reports
          • Tools for Students
          • EEV
          • PPR
      • Certification Information
        • Exams Offered
          • Certification Exams
          • HT/HTL
          • Military Certifications
          • Phlebotomy Programs
  • News
  • News
  • News Archive
  • Groups
  • Jobs
  • ASCP
  • News Archive
  • News Detail

The American Society for Clinical Pathology Calls on the Federal Government to Develop a National COVID-19 Diagnostic Testing and Support Strategy

Publication Date: Apr 14, 2020

ASCP, One of the Nation’s Largest Medical Specialty Societies, is Urging Development of a Widespread Testing Strategy for States, Healthcare Systems, Providers and Clinical Laboratories to Address Patient Care Needs During Pandemic

The American Society for Clinical Pathology (ASCP) is calling on the federal government to immediately develop and implement a widespread COVID-19 Diagnostic Testing and Support Strategy to help mitigate the Coronavirus Disease (COVID-19) pandemic and deter its spread. The plan will be used by states, healthcare systems, providers, clinical laboratories and others to address patient care needs in this crisis.

"It is imperative that we save lives by implementing a national diagnostic testing and support strategy,” said ASCP President Gene P. Siegal, MD, PhD, FASCP. “The federal government has estimated that hundreds of thousands of lives are at stake. Therefore, in order to flatten the curve, we are calling on the federal government to immediately coordinate resources and work with scientists, the public health community, the private sector and state governments to ensure that we reduce and eliminate unnecessary COVID-19 infections and deaths." 

This strategy must include an expanded laboratory testing infrastructure to empower healthcare systems and clinical laboratories nationwide to provide appropriate diagnostic testing to all patients with or without COVID-19 symptoms, as well as healthcare workers, first responders and other individuals who may have been exposed to the virus. 

The goal for widespread, available laboratory testing is to provide patients with a reliable diagnostic test when medically appropriate. In addition, the federal government should also significantly enhance the capabilities of existing surveillance programs to identify outbreaks earlier so that they can be better contained.

This National Diagnostic Laboratory Testing and Support Strategy should, at a minimum, include:

  • The public and private health care sectors are called on to work in concert to rapidly expand appropriate and expeditious diagnostic laboratory testing for the virus responsible for COVID-19, the SARS-CoV-2 virus, to the at-risk population coupled with contact tracing. 
  • Molecular testing is the gold standard for diagnosing COVID-19, and it should be the first test of choice for the diagnosis of acute COVID-19 infection. These rapid diagnostics represent the most accurate test methodologies for the detection of the SARS-CoV-2 virus gene sequences during early stage of infection. 
  • The federal government should provide funding to diagnostics manufacturers, clinical laboratories and other entities engaged in diagnostics research to support the development of innovative testing devices or components that improve the accuracy and reliability and/or turnaround time of diagnostic or screening tests for COVID-19.
  • COVID-19 serology (IgG/IgM) tests should not be used for the acute diagnosis of COVID-19 as it will miss individuals in the early stage of disease progression, including early stage asymptomatic infection, and cannot reliably identify individuals currently infected with the virus.
  • The integration of accurate and reliable serologic laboratory testing needs to be coordinated with the appropriate experts to ensure that community exposure, prevalence and reliable markers of individual immunity can be accurately and reliably identified.
  • Provide support for the use of convalescent plasma as a therapeutic modality for patient care by providing adequate reimbursement.  Reimbursement should also include remuneration for appropriate donors to help defray their medical costs.
  • Congress has guaranteed coverage of testing for COVID-19. This guarantee should be extended to cover diagnostic, screening, and other COVID-19-related testing costs. Moreover, for uninsured patients, the federal and state governments should pay for these tests and subsidize their COVID-19 treatment/hospital costs.
  • The federal government must provide adequate payment for COVID-19 diagnostic and screening tests to ensure clinical laboratories can obtain the financial resources to develop and/or provide these tests.
  • Support for our nation’s public health, community, academic, and private laboratories need to include a supply chain distribution model that will ensure that laboratory testing supply shortages (e.g., swabs, viral transport media, etc.) are addressed immediately.
  • Optimized supply chain management must also assure the safety of our laboratory teams’ (and all healthcare professionals) through the timely availability of personal protective equipment (PPE) to include gloves, masks and face shields, gowns or laboratory coats, and respirators (when appropriate) from point of patient specimen collection through laboratory testing.
  • Financial support should be provided to CLIA-certified anatomic pathology and clinical laboratories during the pandemic and during its immediate aftermath to ensure continued operations to support continuity of patient care.  Without such support, the loss of revenue associated with the suspension of elective testing procedures threatens the financial viability of these laboratories and their ability to help expand our nation’s testing capacity. 
  • Financial support, in the form of grants and/or student loan forgiveness, should be provided to pathology residents, medical students, and laboratory professionals providing services during the COVID-19 pandemic to defray the costs of academic education and clinical training to ensure that anatomic pathology and clinical laboratories have access to the skilled workforce needed to remain fully operational.
  • Expand the authority of the Secretary of Health and Human Services during a declared public health emergency to waive or provide regulatory flexibility with regard to the federal government’s authority over the development of diagnostics and related supplies/components (FDA per the Federal Food, Drug, and Cosmetic Act and CMS per the Clinical Laboratory Improvement Amendments (CLIA) of 1988) and laboratory testing operations (CMS per CLIA).
  • Healthcare providers, including pathologists, laboratory professionals and other members of the COVID-19 response healthcare team, are putting themselves at extreme risk and are working long hours providing care for patients in need.  The federal government and payers should provide hazard pay for individuals involved in diagnosing, treating, and screening patients who may have COVID-19 as well as those professionals who perform forensic pathology and death investigations.  These benefits should be made available to the beneficiaries of healthcare professionals who succumb to COVID-19.
  • The federal government should provide the Secretary of Health and Human Services with the authority to compel hospitals, public and private laboratories and other providers to report information, such as laboratory test performance data and patient-specific symptomatic information, pertinent to ensure robust public health surveillance capabilities.

By implementing a national testing strategy, we can slow the spread of COVID-19. In doing so, we not only help patients, we also alleviate the mounting pressure on healthcare systems across the country. For more information, visit www.ascp.org/COVID-19.

To learn more about ePolicy News and access past newsletters and articles, click here. 

For more information regarding ASCP's advocacy initiatives and policy positions, please contact ASCP's Center for Public Policy at (202) 408-1110.  

hologic-corp

ASCP ePolicy News is supported by an unrestricted grant from Hologic.

 

 

 

 

Footer
  • Membership
    • Membership Overview
    • Member Resources
    • My Role
    • Career Resources
  • Learning
    • Online Education
    • Certificate Programs
    • Quality Improvement & Quality Assurance
    • Live Events
    • Books & Journals
    • Resources
    • ASCPedia
    • ACCME Accreditation
  • Advocacy & Outreach
    • Institute for Science, Technology, and Public Policy
    • Center for Global Health
    • ASCP Foundation
    • Patient Champions
    • Get Involved
  • About ASCP
    • Contact Us
  • Board Of Certification
    • Get Credentialed
    • Stay Credentialed
    • Verify Credentials
    • Program Directors
    • About the BOC
  • News
    • ePolicy News
Chicago (Headquarters)
33 West Monroe Street, Suite 1600, Chicago, IL 60603

Privacy Policy 

Terms of Use

Follow Us

Copyright ©2021 by American Society for Clinical Pathology. All Rights Reserved.